PCP prophylaxis in the '90s

A. C. Furman, K. A. Sepkowitz

Research output: Contribution to journalShort surveypeer-review

Abstract

Pneumocystis carinii pneumonia (PCP) will remain an ominous opportunistic infection because of growing numbers of immunocompromised patients, including those who are infected with the human immunodeficiency virus (HIV), or have organ or bone marrow transplants. Reductions in morbidity and mortality can be achieved, however, by identifying early those patients in high-risk groups and by administering preventive treatment. The authors here discuss current recommendations for PCP prophylaxis (TMP-SMX, pentamidine, and dapsone) in HIV-infected and non-HIV-infected individuals.

Original languageEnglish
Pages (from-to)14-17
Number of pages4
JournalIM - Internal Medicine
Volume15
Issue number7
StatePublished - 1994
Externally publishedYes

Fingerprint

Dive into the research topics of 'PCP prophylaxis in the '90s'. Together they form a unique fingerprint.

Cite this